Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
The company has has 10 existing labs in India
The funds will be used to scale up existing operations and launch new products
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
Owkin builds best-in-class predictive biomedical AI models and robust data sets
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The week-long campaign received a record 17.691 pledges
Hospitals and outpatient clinics can also digitally navigate patients from the time an order is placed, to when it is scheduled and completed through follow-up
Subscribe To Our Newsletter & Stay Updated